SMi's 6th Annual Biomarkers Summit 2013 - Innovations In Stratified Medicine, 16-17 January 2013, London

Date: Jan-14-2013Get all the details on imaging biomarkers of cancer progression to tumor adaptations and see all the new sessions, speakers and formats we've introduced to make SMi's 6th Biomarkers Summit the best event in the pharmaceutical industry. Attend and stay competitive with fresh insights from companies at the cutting edge of biopharmaceutical development.

SMi is pleased to confirm Jill Walker, Diagnostics Director, AstraZeneca as a speaker at the event. Jill will discuss Identifying patient subpopulations with improved response, adapting development strategies to deliver companion diagnostics and ensuring access to diagnostics

Conference Highlights:
Case studies in idiopathic pulmonary fibrosis (IPF) and molecular characterisation of solid tumors
Interactive panel discussion focusing on current developments in personalised medicine via biomarkers
Latest advancements in molecular diagnostics and multi-centre clinical imaging studies 
New developments in pharmacogenetic and pharmacogenomic statistical study design
Future direction and initiatives for safety biomarkers
Maximise the cost-effectiveness of your companion diagnostic for end-users

For more information visit http://www.smi-online.co.uk/goto/biomarkers-summit81.asp alternatively contact Cem Tuna on +44 0 207 827 6184 or email on ctuna@smi-online.co.uk
Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.